Financials

  • Market Capitalization 314.64 M
  • Employee 106
  • Founded 2014
  • CEO N/A
  • Website www.zentalis.com
  • Headquarter California, United States
  • FIGI BBG00R2K8TF5
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-1.34
Fiyat/satışlar oranı
411.04

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
3220
CTNM
Contineum Therapeutics, Inc. - Common stock
14.45 USD-1.90%+2.48%+21.12%-5.37%333.78 M USD
3254
VNDA
Vanda Pharmaceuticals Inc. - Common Stock
5.34 USD-0.19%-2.55%-10.55%-3.44%321.12 M USD
3295
INDP
Indaptus Therapeutics, Inc. - Common Stock
2.72 USD+2.64%+6.25%-29.53%+43.16%308.02 M USD
3305
PRLD
Prelude Therapeutics Incorporated - Common Stock
3.81 USD-3.05%-9.72%-12.61%+314.13%303.45 M USD

Haberler